Reverse Genetics of TheParamyxoviridae

Advances in Virus Research

Volumn 53, Issue C, 1999, Pages 321-340

  Marriott, Anthony C ^a   Easton, Andrew J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MEASLES VIRUS; PARAMYXOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VIRUS GENOME;

ANIMALS; GENOME, VIRAL; HUMANS; MORBILLIVIRUS; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RUBULAVIRUS; TRANSCRIPTION, GENETIC;

EID: 0033258363     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)60354-1     Document Type: Article

References (68)

1. Atreya, P.L., Peeples, M.E., Collins, P.L., The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J. Virol. 72 (1998), 1452–1461.
2. Ball, L.A., Fidelity of homologous recombination in vaccinia virus DNA. Virology 209 (1995), 688–691.
3. Baron, M.D., Barrett, T., Rescue of rinderpest virus from cloned cDNA. J. Virol. 71 (1997), 1265–1271.
4. Buchholz, U.J., Finke, S., Conzelmann, K.-K., Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73 (1999), 251–259.
5. Bukreyev, A., Camargo, E., Collins, P.L., Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70 (1996), 6634–6641.
6. Bukreyev, A., Whitehead, S.S., Murphy, B.R., Collins, P.L., Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71 (1997), 8973–8982.
7. Bukreyev, A., Whitehead, S.S., Bukreyeva, N., Murphy, B.R., Collins, P.L., Interferon γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 2367–2372.
8. Calain, P., Roux, L., Functional characterisation of the genomic and antigenomic promoters of Sendai virus. Virology 212 (1995), 163–173.
9. Calain, P., Curran, J., Kolakofsky, D., Roux, L., Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191 (1992), 62–71.
10. Cathomen, T., Mrkic, B., Spehner, D., Drillien, R., Naef, R., Pavlovic, J., Aguzzi, A., Billeter, M.A., Cattaneo, R., A matrix-less measles virus is infectious and elicits extensive cell fusion: Consequences for propagation in the brain. EMBO J. 17 (1998), 3899–3908.
11. Collins, P.L., Mink, M.A., Stec, D.S., Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 9663–9667.
12. Collins, P.L., Hill, M.G., Camargo, E., Grosfeld, H., Chanock, R.M., Murphy, B.R., Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 92 (1995), 11563–11567.
13. Collins, P.L., Chanock, R.M., McIntosh, K., Parainfluenza viruses. Fields, B.N., Knipe, D.M., Howley, P.M., (eds.) ‘Fields Virology” 3rd ed., 1, 1996, Lippincott-Raven, Philadelphia, 1205–1241.
14. Collins, P.L., Hill, M.G., Cristina, J., Grosfeld, H., Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 81–85.
15. Delenda, C., Hausmann, S., Garcin, D., Kolakofsky, D., Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228 (1997), 55–62.
16. Delenda, C., Taylor, G., Hausmann, S., Garcin, D., Kolakofsky, D., Sendai viruses with altered P, V, and W protein expression. Virology 242 (1998), 327–337.
17. Durbin, A.P., Hall, S.L., Siew, J.W., Whitehead, S.S., Collins, P.L., Murphy, B.R., Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235 (1997), 323–332.
18. Fuerst, T.R., Niles, E.G., Studier, F.W., Moss, B., Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 8122–8126.
19. Garcin, D., Pelet, T., Calain, P., Roux, L., Curran, J., Kolakofsky, D., A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14 (1995), 6087–6094.
20. Garcin, D., Itoh, M., Kolakofsky, D., A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238 (1997), 424–431.
21. Garcin, D., Taylor, G., Tanebayashi, K., Compans, R., Kolakofsky, D., The short Sendai virus leader region controls induction of programmed cell death. Virology 243 (1998), 340–353.
22. Hardy, R.W., Wertz, G.W., The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J. Virol. 72 (1998), 520–526.
23. Hasan, M.K., Kato, A., Shioda, T., Sakai, Y., Yu, D., Nagai, Y., Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J. Gen. Virol. 78 (1997), 2813–2820.
24. Hausmann, S., Jacques, J.-P., Kolakofsky, D., Paramyxovirus RNA editing and the requirement for hexamer gene length. RNA 2 (1996), 1033–1045.
25. He, B., Paterson, R.G., Ward, C.D., Lamb, R.A., Recovery of infectious SV5 from cloned cDNA and expression of a foreign gene. Virology 237 (1997), 249–260.
26. He, B., Leser, G.P., Paterson, R.G., Lamb, R.A., The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250 (1998), 30–40.
27. Hoffman, M.A., Banerjee, A.K., An infectious clone of human parainfluenza virus type 3. J. Virol. 71 (1997), 4272–4277.
28. Itoh, M., Isegawa, Y., Hotta, H., Homma, M., Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J. Gen. Virol. 78 (1997), 3207–3215.
29. Jin, H., Clarke, D., Zhou, H.Z.-Y., Cheng, X., Coelingh, K., Bryant, M., Li, S., Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology 251 (1998), 206–214.
30. Juhasz, K., Whitehead, S.S., Bui, P.T., Biggs, J.M., Boulanger, C.A., Collins, P.L., Murphy, B.R., The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts 530, results from a single amino acid substitution in the L protein. J. Virol. 71 (1997), 5814–5819.
31. Juhasz, K., Murphy, B.R., Collins, P.L., The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts 530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature sensitive alteration in mRNA termination. J. Virol. 73 (1999), 5176–5180.
32. Kato, A., Sakai, Y., Shioda, T., Kondo, T., Nakanishi, M., Nagai, Y., Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1 (1996), 569–579.
33. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Nagai, Y., The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16 (1997), 578–587.
34. Kolakofsky, D., Pelet, T., Garcin, D., Hausmann, S., Curran, J., Roux, L., Paramyxovirus RNA synthesis and the requirement for hexamer genome length: The rule of six revisited. J. Virol. 72 (1998), 891–899.
35. Kuo, L., Fearns, R., Collins, P.L., The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J. Virol. 70 (1996), 6143–6150.
36. Kuo, L., Fearns, R., Collins, P.L., Analysis of the gene start and gene end signals of human respiratory syncytial virus: Quasi-templated initiation at position 1 of the encoded mRNA. J. Virol. 71 (1997), 4944–4953.
37. Latorre, P., Cadd, T., Itoh, M., Curran, J., Kolakofsky, D., The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72 (1998), 5984–5993.
38. Leyrer, S., Bitzer, M., Lauer, U., Kramer, J., Neubert, W.J., Sedlmeier, R., Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor. J. Gen. Virol. 79 (1998), 683–687.
39. Marriott, A.C., Wilson, S.D., Randhawa, J.S., Easton, A.J., A single amino acid substitution in the phosphoprotein of respiratory syncytial virus confers thermosensitivity in a reconstituted RNA polymerase system. J. Virol. 73 (1999), 5162–5165.
40. Park, K.H., Krystal, M., In vivo model for pseudo-templated transcription in Sendai virus. J. Virol. 66 (1992), 7033–7039.
41. Park, K.H., Huang, T., Correia, F.F., Krystal, M., Rescue of a foreign gene by Sendai virus. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 5537–5541.
42. Peeters, B.P.H., de Leeuw, O.S., Koch, G., Gielkens, A.L.J., Rescue of Newcastle disease virus from cloned cDNA: Evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73 (1999), 5001–5009.
43. Pelet, T., Delenda, C., Gubbay, O., Garcin, D., Kolakofsky, D., Partial characterization of a Sendai virus replication promoter and the rule of six. Virology 224 (1996), 405–414.
44. Pringle, C.R., Easton, A.J., Monopartite negative strand RNA genomes. Semin. Virol. 8 (1997), 49–57.
45. Radecke, F., Billeter, M.A., The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217 (1996), 418–421.
46. Radecke, F., Spielhofer, P., Schneider, H., Kaelin, K., Huber, M., Dötsch, C., Christiansen, G., Billeter, M.A., Rescue of measles viruses from cloned DNA. EMBO J. 14 (1995), 5773–5784.
47. Randhawa, J.S., Marriott, A.C., Pringle, C.R., Easton, A.J., Rescue of synthetic minireplicons establishes the absence of the NS1 and NS2 genes from avian pneumovirus. J. Virol. 71 (1997), 9849–9854.
48. Sakaguchi, T., Kiyotani, K., Kato, A., Asakawa, M., Fujii, Y., Nagai, Y., Yoshida, T., Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 235 (1997), 360–366.
49. Samal, S.K., Collins, P.L., RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J. Virol. 70 (1996), 5075–5082.
50. Schneider, H., Kaelin, K., Billeter, M.A., Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227 (1997), 314–322.
51. Schneider, H., Spielhofer, P., Kaelin, K., Dötsch, C., Radecke, F., Sutter, G., Billeter, M.A., Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J. Virol. Methods 64 (1997), 57–64.
52. Schnell, M.J., Mebatsion, T., Conzelmann, K.-K., Infectious rabies viruses from cloned cDNA. EMBO J. 13 (1994), 4195–4203.
53. Sidhu, M.S., Chan, J., Kaelin, K., Spielhofer, P., Radecke, F., Schneider, H., Masurekar, M., Dowling, P.C., Billeter, M.A., Udem, S.A., Rescue of synthetic measles virus minireplicons: Measles genomic termini direct efficient expression and propagation of a reporter gene. Virology 208 (1995), 800–807.
54. Singh, M., Billeter, M.A., A recombinant measles virus expressing biologically active human interleukin-12. J. Gen. Virol. 80 (1999), 101–106.
55. Singh, M., Cattaneo, R., Billeter, M.A., A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J. Virol 73 (1999), 4823–4828.
56. Skiadopoulos, M.H., Durbin, A.P., Tatem, J.M., Wu, S.-L., Paschalis, M., Tao, T., Collins, P.L., Murphy, B.R., Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp 45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes. J. Virol. 72 (1998), 1762–1768.
57. Skiadopoulos, M.H., Surman, S., Tatem, J.M., Paschalis, M., Wu, S.-L., Udem, S.A., Durbin, A.P., Collins, P.L., Murphy, B.R., Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp 45) human parainfluenza virus 3 candidate vaccine. J. Virol. 73 (1999), 1374–1381.
58. Tao, T., Durbin, A.P., Whitehead, S.S., Davoodi, F., Collins, P.L., Murphy, B.R., Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1. J. Virol. 72 (1998), 2955–2961.
59. Teng, M.N., Collins, P.L., Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J. Virol. 72 (1998), 5707–5716.
60. Teng, M.N., Collins, P.L., Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J. Virol. 73 (1999), 466–473.
61. Tober, C., Seufert, M., Schneider, H., Billeter, M.A., Johnston, I.C.D., Niewiesk, S., ter Meulen, V., Schneider-Schaulies, S., Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72 (1998), 8124–8132.
62. Valsamakis, A., Schneider, H., Auwaerter, P.G., Kaneshima, H., Billeter, M.A., Griffin, D.E., Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72 (1998), 7754–7761.
63. Whitehead, S.S., Juhasz, K., Firestone, C.-Y., Collins, P.L., Murphy, B.R., Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from coldpassaged RSV is attenuated in chimpanzees. J. Virol. 72 (1998), 4467–4471.
64. Whitehead, S.S., Firestone, C.-Y., Collins, P.L., Murphy, B.R., A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts-248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Virology 247 (1998), 232–239.
65. Whitehead, S.S., Bukreyev, A., Teng, M.N., Firestone, C.-Y., St. Claire, M., Elkins, W.R., Collins, P.L., Murphy, B.R., Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J. Virol. 73 (1999), 3438–3442.
66. Whitehead, S.S., Firestone, C.-Y., Karron, R.A., Crowe, J.E.J., Elkins, W.R., Collins, P.L., Murphy, B.R., Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts 530/1030 to RSV vaccine candidate cpts 248/404 increases its attenuation and temperature sensitivity. J. Virol. 73 (1999), 871–877.
67. Wyatt, L.S., Moss, B., Rozenblatt, S., Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210 (1995), 202–205.
68. Yu, Q., Hardy, R.W., Wertz, G.W., Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 69 (1995), 2412–2419.